Cargando…

Development and evaluation of a psychosocial adaptation questionnaire for women with breast cancer treated with adjuvant endocrine therapy: a single-centre, cross-sectional study in China

OBJECTIVE: To develop and evaluate a psychosocial adaptation (PSA) questionnaire of women with breast cancer treated with adjuvant endocrine therapy (AET). DESIGN: Cross-sectional study. SETTING: Conducted study in a tertiary care centre in China from March to June 2021. PARTICIPANTS: Women with bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Haoran, Zhang, Xiujie, Dong, Yu, Xu, Hui, Jin, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680142/ https://www.ncbi.nlm.nih.gov/pubmed/36410798 http://dx.doi.org/10.1136/bmjopen-2022-063082

Ejemplares similares

The relationship among psychosocial adaptation, medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy
por: Jiang, Haoran, et al.
Publicado: (2022)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
por: Buono, Giuseppe, et al.
Publicado: (2022)

Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials
por: Xie, Ming, et al.
Publicado: (2022)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer
por: Sehdev, S., et al.
Publicado: (2009)

Prevalence of psychological distress and associated factors among Omani women diagnosed with breast cancer: a single-centre, cross-sectional study
por: Al-Fahdi, Amal, et al.
Publicado: (2023)

Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients
por: Tong, Yiwei, et al.
Publicado: (2022)

Development of health behaviour questionnaire for breast cancer women in Mainland China
por: Xu, Hui, et al.
Publicado: (2020)

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor– positive early breast cancer
por: Verma, S., et al.
Publicado: (2009)

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience
por: Bimbatti, Davide, et al.
Publicado: (2022)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
por: Kang, Yi-Kun, et al.
Publicado: (2021)

Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer
por: Flores-Balcázar, Christian H, et al.
Publicado: (2018)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Adjuvant single-fraction radiotherapy is safe and effective for intractable keloids
por: Song, Changhoon, et al.
Publicado: (2014)

Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials
por: Hu, Qiancheng, et al.
Publicado: (2023)

Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy
por: Araújo, Rita, et al.
Publicado: (2022)

Study protocol for a randomised controlled feasibility trial of a virtual intervention (STRIDE) for symptom management, distress and adherence to adjuvant endocrine therapy after breast cancer
por: Jacobs, Jamie M, et al.
Publicado: (2021)

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy
por: Zhou, Ying, et al.
Publicado: (2022)

Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors
por: Ates, Ozturk, et al.
Publicado: (2016)

The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy
por: Hilaj, Erina, et al.
Publicado: (2020)

Development and Validation of an Italian Adaptation of the Psychosocial Aspects of Hereditary Cancer Questionnaire
por: Franiuk, Marzena, et al.
Publicado: (2021)

(177)Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East Asians
por: Bu, Ting, et al.
Publicado: (2022)

Cross-cultural adaptation and validation of the Chinese version of the Spine Oncology Study Group Outcomes Questionnaire
por: Zhai, Shuheng, et al.
Publicado: (2022)

Adjuvant chemoradiotherapy does not improve outcomes in patients with fistula-associated anal adenocarcinoma undergoing abdominoperineal resection
por: Wang, Min, et al.
Publicado: (2022)

Adjuvant Radiation in Older Patients With Glioblastoma: A Retrospective Single Institution Analysis
por: Lee, Jessica W., et al.
Publicado: (2021)

Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study
por: Singer, Susanne, et al.
Publicado: (2022)

Nuclear Mechanisms Involved in Endocrine Resistance
por: Dittmer, Jürgen
Publicado: (2021)

Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China
por: Wu, Yun, et al.
Publicado: (2021)

Effect of Treatment Modality on the Hypothalamic–Pituitary Function of Patients Treated with Radiation Therapy for Pituitary Adenomas: Hypothalamic Dose and Endocrine Outcomes
por: Elson, Andrew, et al.
Publicado: (2014)

Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study
por: Szilcz, Máté, et al.
Publicado: (2023)

Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study
por: Chen, Jie, et al.
Publicado: (2022)

Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2017)

A urethral clear cell carcinoma case successfully treated with organ preservation surgery and adjuvant chemoradiation
por: Lee, Seok Ho, et al.
Publicado: (2022)

Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature
por: Diciolla, A., et al.
Publicado: (2022)

Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization
por: Xu, Jing-Xuan, et al.
Publicado: (2023)

A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer
por: Ono, Miyuki, et al.
Publicado: (2015)

Psychometric properties of the Beliefs about Medicine Questionnaire–adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer
por: Brett, Jo, et al.
Publicado: (2017)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial
por: de Boer, Nadine L, et al.
Publicado: (2019)

Editorial: Psychosocial Advances in Neuro-Oncology
por: Ownsworth, Tamara, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cjls9d1dkccchpo8c8b1r53enb